Page 2 - Eunk Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets
AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader by announcing plans to acquire Alexion Pharmaceuticals for $39 billion, in what would be the largest biopharma acquisition of 2020.[Alexion Pharmaceuticals]
December 14, 2020
AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader by announcing plans to acquire Alexion Pharmaceuticals for $39 billion, in what would be the largest biopharma acquisition of 2020.[Alexion Pharmaceuticals]
Share
AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader on Saturday when it announced plans to acquire Alexion Pharmaceuticals for $39 billion, in what would be the largest biopharma acquisition of 2020. ....

United States , Science Park , New Haven , France General , Geoffreyc Porges , Eunk Yang , Raymond Poincar , Leonard Bell , Ludwig Hantson , Andrew Berens , Pascal Soriot , Portola Pharmaceuticals , Alexion Pharmaceuticals , University Of Oxford , Zeneca American Depositary Shares , American Depositary Receipts , Elliott Advisors , ஒன்றுபட்டது மாநிலங்களில் , அறிவியல் பூங்கா , புதியது புகலிடம் , பிரான்ஸ் ஜநரல் , லியோனார்ட் மணி , ஆண்ட்ரூ பெரன்ஸ் , போர்த்தோழ மருந்துகள் , அலெக்சியன் மருந்துகள் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் ,